1. D-allose protects the blood brain barrier through PPARγ-mediated anti-inflammatory pathway in the mice model of ischemia reperfusion injury.
    Tao Huang et al, 2016, Brain Res CrossRef
  2. New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy
    Qiujun Guo et al, 2016, Journal of Immunology Research CrossRef
  3. Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway.
    Honggang Kang et al, 2017, Int J Oncol CrossRef
  4. Cellular metabolism of tumor-associated macrophages - functional impact and consequences
    Katrin Rabold et al, 2017, FEBS Lett CrossRef
  5. Cancer Stem Cells and Tumor-Associated Macrophages
    W. Zhou et al, 2016 CrossRef
  6. NF-κB pathways are involved in M1 polarization of RAW 264.7 macrophage by polyporus polysaccharide in the tumor microenvironment
    Chun-Ping Liu et al, 2017, PLoS ONE CrossRef
  7. MiRNAs at the Crossroads between Innate Immunity and Cancer: Focus on Macrophages
    Graziella Curtale, 2018, Cells CrossRef
  8. Parity History Determines a Systemic Inflammatory Response to Spread of Ovarian Cancer in Naturally Aged Mice
    Ulises Urzua et al, 2017, A&D CrossRef
  9. Aquaporin-4 deletion ameliorates hypoglycemia-induced BBB permeability by inhibiting inflammatory responses
    Fei Zhao et al, 2018, J Neuroinflammation CrossRef
  10. Regulation of Immune Cell Function by PPARs and the Connection with Metabolic and Neurodegenerative Diseases
    Gwenaëlle Le Menn et al, 2018, IJMS CrossRef
  11. Epithelial ovarian cancer inherent resistance: May the pleiotropic interaction between reduced immunosurveillance and drug-resistant cells play a key role?
    Antonio Simone Laganà et al, 2016, Gynecologic Oncology Reports CrossRef
  12. Platinum sensitivity of ovarian cancer cells does not influence their ability to induce M2-type macrophage polarization
    Agata Mlynska et al, 2018, Am J Reprod Immunol CrossRef
  13. Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy
    Vijayalaxmi Gupta et al, 2018, Cancers CrossRef
  14. Ovarian cancer stem cells: What progress have we made?
    Linah F. Al-Alem et al, 2018, The International Journal of Biochemistry & Cell Biology CrossRef
  15. Autophagy-induced RelB/p52 activation mediates tumour-associated macrophage repolarisation and suppression of hepatocellular carcinoma by natural compound baicalin.
    H-Y Tan et al, 2015, Cell Death Dis CrossRef
  16. Analysis of macrophages and neutrophils infiltrating murine mammary carcinoma sites within hours of tumor delivery
    Chenyu Zhang et al, 2019, Cellular Immunology CrossRef
  17. Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments.
    Shreya Raghavan et al, 2019, J Immunother Cancer CrossRef
  18. Immunotherapy in Ovarian Cancer: Are We There Yet?
    Lana E. Kandalaft et al, 2019, JCO CrossRef
  19. PPARs and the Development of Type 1 Diabetes
    Laurits J. Holm et al, 2020, PPAR Research CrossRef
  20. Targeting cancer stem cell pathways for cancer therapy.
    Liqun Yang et al, 2020, Signal Transduct Target Ther CrossRef
  21. Pharmacological targets of metabolism in disease: Opportunities from macrophages
    Alessandra Castegna et al, 2020, Pharmacology & Therapeutics CrossRef
  22. Tumor associated macrophages in the molecular pathogenesis of ovarian cancer
    Yousef Yousefzadeh et al, 2020, International Immunopharmacology CrossRef
  23. MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway
    Wankun Chen et al, 2016, Oncotarget CrossRef
  24. Immune Therapy Opportunities in Ovarian Cancer
    Lana E. Kandalaft et al, 2020, American Society of Clinical Oncology Educational Book CrossRef

  25. CTHRC1 in Ovarian Cancer Promotes M2-Like Polarization of Tumor-Associated Macrophages via Regulation of the STAT6 Signaling Pathway


    Yihan Bai et al, 2020, OTT CrossRef
  26. Modulation of Immune Infiltration of Ovarian Cancer Tumor Microenvironment by Specific Subpopulations of Fibroblasts
    Ji Wang et al, 2020, Cancers CrossRef
  27. The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy.
    Zhe Ge et al, 2020, Front Oncol CrossRef
  28. Cancer Stemness Meets Immunity: From Mechanism to Therapy.
    Peiwen Chen et al, 2021, Cell Rep CrossRef
  29. Driving Immune Responses in the Ovarian Tumor Microenvironment
    Franklin Ning et al, 2021, Front. Oncol. CrossRef
  30. Research trends in pharmacological modulation of tumor-associated macrophages.
    Neng Wang et al, 2021, Clin Transl Med CrossRef
  31. Ovarian cancer immunotherapy of NF-κB may have a dark side
    Amr Ahmed El-Arabey et al, 2021, Human Cell CrossRef
  32. IL-10 Signaling in the Tumor Microenvironment of Ovarian Cancer
    Ramesh B. Batchu et al, 2021 CrossRef
  33. Camptothecin Regulates Microglia Polarization and Exerts Neuroprotective Effects via Activating AKT/Nrf2/HO-1 and Inhibiting NF-κB Pathways In Vivo and In Vitro
    Dewei He et al, 2021, Front. Immunol. CrossRef
  34. Insight into the role of multiple signaling pathways in regulating cancer stem cells of gynecologic cancers
    Yizuo Song et al, 2021, Seminars in Cancer Biology CrossRef
  35. The Effects of Simulated Microgravity on Macrophage Phenotype
    Christopher Ludtka et al, 2021, Biomedicines CrossRef
  36. Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers
    Tianhan Xu et al, 2021, J Hematol Oncol CrossRef
  37. Role of ROS in Cancer Stem Cells
    Sharmistha Chatterjee et al, 2021 CrossRef
  38. Role of ROS in Cancer Stem Cells
    Sharmistha Chatterjee et al, 2022 CrossRef
  39. Viola yedoensis Makino formula alleviates DNCB-induced atopic dermatitis by activating JAK2/STAT3 signaling pathway and promoting M2 macrophages polarization
    Hairong Zeng et al, 2022, Phytomedicine CrossRef
  40. Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells
    Shahang Luo et al, 2022, Biomolecules CrossRef
  41. Ovarian cancer stem cells: Critical roles in anti-tumor immunity
    Jing Ding et al, 2022, Front. Genet. CrossRef
  42. Crosstalk between the aryl hydrocarbon receptor (AhR) and the peroxisome proliferator-activated receptor gamma (PPARγ) as a key factor in the metabolism of silver nanoparticles in neuroblastoma (SH-SY5Y) cells in vitro
    Bartosz Skóra et al, 2022, Toxicology and Applied Pharmacology CrossRef
  43. Global Gene Networks in 3D4/31 Porcine Alveolar Macrophages Treated with Antigenic Epitopes of Actinobacillus pleuropneumoniae ApxIA, IIA, and IVA
    Suji Kim et al, 2019, Sci Rep CrossRef
  44. Natural products targeting macrophages in tumor microenvironment are a source of potential antitumor agents
    Qiu-Ping Liu et al, 2022, Phytomedicine CrossRef
  45. Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches
    Ivan Lučić et al, 2023, IJMS CrossRef
  46. Molecular Mechanisms Underpinning Immunometabolic Reprogramming: How the Wind Changes during Cancer Progression
    Irene Flati et al, 2023, Genes CrossRef
  47. Tumor-associated macrophages: an effective player of the tumor microenvironment
    Udit Basak et al, 2023, Front. Immunol. CrossRef
  48. An individualized stemness‐related signature to predict prognosis and immunotherapy responses for gastric cancer using single‐cell and bulk tissue transcriptomes
    Linyong Zheng et al, 2024, Cancer Medicine CrossRef
  49. Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors
    Shahil Alam et al, 2024, Cancer Drug Resist CrossRef
  50. Dual function of activated PPARγ by ligands on tumor growth and immunotherapy
    Mingjun Chen et al, 2024, Med Oncol CrossRef
  51. PPARγ activation modulates the balance of peritoneal macrophage populations to suppress ovarian tumor growth and tumor-induced immunosuppression
    Mélissa Prat et al, 2023, J Immunother Cancer CrossRef
  52. Lipid-based nanosystems: the next generation of cancer immune therapy
    Ziyun Cheng et al, 2024, J Hematol Oncol CrossRef